(Total Views: 665)
Posted On: 12/21/2020 7:10:36 PM
Post# of 30015
Interesting OncBioMune Pharmaceuticals acquired Avant Diagnostics, Inc for 4.4 billion shares of OncBioMune’s common stock. Which AMBS owns 31% of Avant diagnostics, could receive 1.36B shares of $OBMP.
IS THIS TRUE?
IS THIS TRUE?
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)